Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)
ClinicalTrials.gov study NCT03631576. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD123-CD16-NK Cells Immunotherapy for AML
ClinicalTrials.gov study NCT06835140. IPD Sharing: NO. Countries: 1. Publications: 0.
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
ClinicalTrials.gov study NCT05188170. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML
ClinicalTrials.gov study NCT04842370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
ClinicalTrials.gov study NCT01794169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MG4101 for Refractory or Relapsed AML
ClinicalTrials.gov study NCT03349502. IPD Sharing: NO. Countries: 1. Publications: 0.
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
ClinicalTrials.gov study NCT05636514. IPD Sharing: NO. Countries: 1. Publications: 0.
Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00129948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CART123 + Ruxolitinib in Relapsed/Refractory AML
ClinicalTrials.gov study NCT06768476. IPD Sharing: NO. Countries: 1. Publications: 0.
Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.
ClinicalTrials.gov study NCT04904237. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay
ClinicalTrials.gov study NCT04240600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
ClinicalTrials.gov study NCT06504459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT06498973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00322673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real World Outcomes Using Novel Agents for AML in the UK
ClinicalTrials.gov study NCT05312112. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS
ClinicalTrials.gov study NCT04901416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation
ClinicalTrials.gov study NCT04796441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
ClinicalTrials.gov study NCT03825367. IPD Sharing: NO. Countries: 1. Publications: 0.
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02283190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML
ClinicalTrials.gov study NCT03665480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.